Surf Air Mobility

LATEST GREEN FUTURE STOCK NEWS


Advanced Energy Opens Design and Service Center in the Greater Boston Area

New facility will develop and support advanced power technologies for plasma processes, medical and high-voltage industrial applications DENVER / Sep 19, 2024 / Business Wire / Advanced Energy (Nasdaq: AEIS) – a global leader in highly engineered, precision power conversion, measurement and control solutions – has announced the opening of a new design and service center in Wilmington, MA. The state-of-the art... Read more


Darden and Uber Technologies Partner to Introduce On-Demand Delivery, with Olive Garden the First to Pilot

Olive Garden guests will soon have another option to enjoy their favorite dishes at home, with orders made through Olive Garden channels and delivery powered by Uber Direct; Custom integration preserves team member and guest experience, while growing first-party delivery demand ORLANDO, Fla. and SAN FRANCISCO, Sept. 19, 2024 /PRNewswire/ -- Darden Restaurants, Inc., (NYSE: DRI) and Uber Technologies, Inc.... Read more


Crown Electrokinetics Element 82 Division Secures $10M Contract

LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in constructing fiber optic networks and lead pipe inspection and remediation, today announced that its Element 82 division has secured a contract valued at $10 million for lead pipe inspection. The work is scheduled to begin in... Read more


Sidus Space Enhances LizzieSat Constellation Operations via Agreement with Neuraspace

Neuraspace’s Space Traffic Management (STM) platform provides cutting edge Artificial Intelligence (AI) and Machine Learning (ML) features that reinforce mission safety, efficiency and longevity for Sidus Space. PARIS / Sep 19, 2024 / Business Wire / Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), a provider of end-to-end precision Space Infrastructure solutions and Data-as-a-Service products, announced... Read more


Hut 8 and BITMAIN Expand Innovation Partnership with Launch of Next-Generation BITMAIN Miner

U3S21EXPH to be first ASIC miner mass-commercialized by BITMAIN with direct liquid-to-chip cooling within U form factor Hut 8 plans to deploy model in Q2 2025 through ~15 EH/s hosting deployment with potential transition to self-mining through purchase option MIAMI, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of... Read more


BIGG Digital Assets: Netcoins USA expands its operations to 48 states

VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”) (TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, Blockchain Intelligence Group, and TerraZero is pleased to announce that Netcoins USA has completed its testing phase and is now live to all customers in the United States. Netcoins USA... Read more


Earlyworks and CAICA DIGITAL Entered into a Business Alliance Agreement to Support the Expansion of Web3 Business

TOKYO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (NASDAQ: ELWS) ("Earlyworks" or the "Company"), a blockchain solution provider headquartered in Taito-ku, Tokyo which develops its proprietary blockchain technology, Grid Ledger System ("GLS"), has signed a business alliance agreement with CAICA DIGITAL Inc. ("CAICA"), a company headquartered in Minato-ku, Tokyo which develops system solutions for the... Read more


MineHub Technologies Reports Second Quarter Fiscal 2025 Financial Results

MineHub reported a 21% increase in year-over-year revenue and a 24% reduction in operating expenses for the second quarter of Fiscal 2025 MineHub's customers transacted US$7.3 billion in commodities on the MineHub platform in the first half of Fiscal 2025, an increase of over 15% year-over-year During the quarter, MineHub announced a strategic partnership with Abaxx, a leading digital infrastructure developer... Read more


ValOre Metals Partners with VRIFY to Leverage AI Mineral Targeting Platform to Accelerate Discovery Process

VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ValOre Metals Corp. (“ValOre”; TSX‐V: VO; OTCQB: KVLQF; Frankfurt: KEQ0, “the Company”) today announced a partnership with VRIFY which incorporates VRIFY’s cutting-edge Artificial Intelligence (“AI”) mineral targeting platform. This partnership aims to both accelerate and enhance the mineral discovery process by taking an unbiased data-driven approach... Read more


Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive...

In a Phase 1 in healthy subjects, EDG-7500 was well-tolerated without meaningful changes in left ventricle ejection fraction (LVEF)  CIRRUS-HCM single-dose trial of EDG-7500 in obstructive HCM demonstrated robust left ventricular outflow tract (LVOT) gradient reductions without meaningful changes in LVEF  Company announced dosing of first patients in CIRRUS-HCM 28-day trial  Edgewise to host... Read more


Longboard Pharmaceuticals Receives Rare Pediatric Disease Designation and Orphan Drug Designation for Bexicaserin (LP352) in Dravet Syndrome

U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation and Rare Pediatric Disease designation for bexicaserin for the treatment of Dravet syndrome LA JOLLA, Calif. / Sep 19, 2024 / Business Wire / Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that the... Read more


Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved...

New patent expected to expire in 2030 Tosymra® (sumatriptan nasal spray) 10mg is indicated and marketed for the acute treatment of migraine in adults CHATHAM, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that the... Read more


PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated...

Toronto, Ontario--(Newsfile Corp. - September 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is announcing it has initiated start-up activities for its first clinical study of its... Read more


Ensysce Biosciences Submits Phase 3 Protocol to the FDA

Phase 3 Study to Assess PF614 Efficacy in Treating Post-Surgical Pain SAN DIEGO, CA / ACCESSWIRE / September 19, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced it has submitted to the FDA its PF614-301 protocol... Read more


Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP™)

New U.S. patent covers the design and composition of the BVP  Positive results from ongoing preclinical studies support the potential of the BVP to deliver insulin-producing islets as a potential treatment for type 1 diabetes  DURHAM, N.C., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable,... Read more


Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical...

Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine in 2021, resulting in the first FDA-approved therapy for AL amyloidosis Dr. Comenzo was the lead author on the landmark 2012 publication of consensus guidelines, including response criteria, for conduct and reporting of clinical trials in AL Amyloidosis LOS ANGELES, CA, Sept. 19, 2024... Read more


VERSES AI and Analog Announce Smart City Initiative in Abu Dhabi

Project will simulate taxi fleet management to optimize mobility and transportation CEO Gabriel René and Analog CEO Alex Kipman to Host Webinar on Tuesday, October 1st at 1:00PM PT / 4:00PM ET VANCOUVER, British Columbia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQX:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next generation intelligent systems,... Read more


Orion Energy Systems Secures Over $2 Million in LED Lighting Retrofit Projects from Leading U.S. Automotive OEM

MANITOWOC, Wis., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations, and maintenance services solutions, today announced it has been awarded projects totaling more than $2 million from a longstanding automotive OEM customer. These projects encompass the project management, installation,... Read more


Nuvalent Announces Closing of Upsized Public Offering of Common Stock

CAMBRIDGE, Mass., Sept. 18, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the closing of its previously announced upsized underwritten public offering of 5,750,000 shares of Class A common stock, which includes 750,000 shares of Class A common... Read more


Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

RADNOR, Pa., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001. IGI’s drug candidate is a trispecific T-cell engager (TCE) being studied as a potential cancer treatment. Preclinical research and... Read more


Tonix Pharmaceuticals: New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution

CHATHAM, NJ / ACCESSWIRE / September 18, 2024 / The mpox virus, formerly known as monkeypox, has increasingly become a global health concern, especially with rising cases of a new lethal strain across Africa and parts of Europe and Asia. In response to the spread of this dangerous disease, the World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) and highlighted an... Read more


Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences

Stockholders must vote by 11:59 p.m. ET on September 19, 2024 for their vote to count A "FOR" vote on Proposals 3 & 5 by holders of a majority of the voting power of Kintara's outstanding shares as of August 14, 2024 is required to allow for completion the proposed merger with TuHURA Biosciences SAN DIEGO, Sept. 18, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a... Read more


Roivant Sciences: Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional indication to treat atopic dermatitis Proposed acquisition extends Organon’s international dermatology capabilities to the U.S. BASEL, Switzerland and LONDON and NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Organon (NYSE: OGN), a global healthcare company with a... Read more


Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology

BOSTON, Sept. 18, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, proudly announces the launch of Ginkgo Datapoints to usher in the next era of biotechnology by making the training of AI models easier and more efficient. Ginkgo Datapoints is specialized in generating large, high-quality biological datasets with a fast... Read more


BriaCell Therapeutics Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

FDA has authorized the Expanded Access Policy (EAP) to help metastatic breast cancer patients in need for novel treatments Expanded access policy will provide potential lifesaving Bria-IMT™ to those cancer patients in need beyond the scope of BriaCell’s pivotal Phase 3 clinical trial. PHILADELPHIA and VANCOUVER, British Columbia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (NASDAQ: BCTX,... Read more


Peer-Reviewed Study: bioAffinity Technologies’ CyPath Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical...

Study by BAMC’s Michael Morris, M.D., and VA’s Sheila Habib, M.D., evaluated potential economic impact of CyPath® Lung for the early detection of lung cancer SAN ANTONIO, Texas / Sep 18, 2024 / Business Wire / A new economic study found that adding CyPath® Lung, bioAffinity Technologies’ noninvasive test for detection of early-stage lung cancer, to the standard of care for Medicare patients with a positive lung... Read more


Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures

TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures, announced today its strategic focus on dedicating its resources to advancing the clinical development of Bucillamine, an oral... Read more


Draganfly and Nightingale Security Selected by Fortune 25 Oil and Gas Company to Develop Autonomous Drone-in-a-Box Remote Sensing Solution

Draganfly and Nightingale to Deliver Automated Drone Solution for Oil and Gas Monitoring Saskatoon, SK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning industry-leading drone solutions and systems developer, along with Nightingale Security, a leader in robotic... Read more


NASA Awards Intuitive Machines Near Space Network Contract with a Maximum Potential Value of $4.82 Billion

HOUSTON, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) (“Intuitive Machines”) (“Company”), a leading space exploration, infrastructure, and services company, today announced NASA has awarded the Company a Near Space Network (“NSN”) contract for communication and navigation services for missions in the near space region, which extends from Earth’s surface to beyond the Moon. This... Read more


Nauticus Robotics Announces Second Round of Aquanaut Mark 2 Deepwater Qualification Testing

HOUSTON, Sept. 17, 2024 /PRNewswire/ -- Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in autonomous subsea robotics and software, began its second round of qualification testing of its flagship underwater vehicle, Aquanaut Mark 2, in the Gulf of Mexico (GOM). Vehicle 2 will be used for commercial operations going forward. Completion of this testing is intended to certify the vehicle for water depths... Read more


New Horizons: Volcon Signs Distribution Agreement in Japan, Introducing the Brat Café Racer Configuration

AUSTIN, Texas, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Volcon Inc. (NASDAQ:VLCN), ("Volcon" or the "Company"), the first all-electric, off-road powersports company, is pleased to announce a new distribution agreement with a prominent Japanese vehicle distributor. This relationship will see the introduction of Volcon’s popular Brat electric bike with unique café racer options. The Brat is expected to be available for... Read more


CleanSpark Acquires Two Additional Sites in Mississippi and Closes Second Site in Wyoming

LAS VEGAS, Sept. 17, 2024 /PRNewswire/ -- CleanSpark Inc. (Nasdaq: CLSK), America's Bitcoin Miner® (the "Company") today announced it has acquired two Bitcoin mining sites and associated land near Clinton, Mississippi, and closed on its second site in Wyoming. The Mississippi acquisitions have a combined purchase price of $5.775 million and will support a total of 16.5 MW. The sites are currently partially... Read more


LQWD Technologies Forms Strategic Partnership with Alby as Key Liquidity Service Provider for Alby Hub

VANCOUVER, BC / ACCESSWIRE / September 17, 2024 / LQWD Technologies Corp. (TSXV:LQWD)(OTCQB:LQWDF), a leading institutional provider of Lightning Network Liquidity services, is pleased to announce a strategic partnership with Alby Inc. ("Alby"), a pioneering technology company specializing in the Lightning Network, Bitcoin's Layer 2 scaling solution. This collaboration positions LQWD as a key liquidity service... Read more


Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians this fall and winter season. Moderna will promptly begin delivery of updated COVID-19 vaccines to the Public Health Agency of Canada, so there is robust supply available in time for provincial and territorial vaccination campaigns. CAMBRIDGE, MA / ACCESSWIRE / September 17,... Read more


BridgeBio Pharma Announces Infigratinib Is the First Ever Investigational Therapeutic Option for Achondroplasia to Be Awarded Breakthrough Therapy Designation...

Breakthrough Therapy Designation was granted based on preliminary clinical evidence from the PROPEL 2 clinical trial, meeting the FDA’s requirement of potentially demonstrating substantial improvement in efficacy over available therapies on clinically significant endpoint(s) BridgeBio will leverage the benefits of Breakthrough Therapy Designation to expedite the development and regulatory review of infigratinib... Read more


Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System...

BRAINTREE, Mass., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced that it has successfully reached the midpoint of the ACCESS-PVI pivotal human clinical trial, enrolling and completing the follow up of 50% of the patients participating in the trial to evaluate the LIBERTY® Endovascular Robotic... Read more


TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate

Two patients dosed; several additional patients screened for enrollment Trial to evaluate safety and tolerability of TTX-MC138 in patients with metastatic cancer TTX-MC138 is an antisense oligonucleotide conjugated to TransCode’s proprietary TTX delivery system designed to inhibit microRNA-10b, a known driver of metastasis in multiple cancers Phase 1 clinical trial follows evidence of delivery and... Read more


Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology

Protein large language model (LLM) designed to help enterprises accelerate drug development coming to Google Cloud's Vertex AI Model Garden soon; one of the first-of-its-kind in the industry Model API programmable interface now available for individual scientists and researchers to quickly test and advance work BOSTON, Sept. 17, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), which is... Read more


Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment...

WAYNE, Pa., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that the first patient has been dosed in Aclaris' Phase 2a clinical trial of ATI-2138, an investigational oral covalent inhibitor of interleukin-2-inducible T cell kinase (ITK) and Janus... Read more


Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER Trial

BASKING RIDGE, N.J., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced treatment of the first patient in the second-line cholangiocarcinoma (“CCA”) cohort of the BOLSTER trial. This follows the recently... Read more

COPYRIGHT ©2022 GREEN STOCK NEWS